Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice
Objective: Individuals born with intrauterine growth retardation (IUGR) are more prone to cardio-metabolic diseases as adults, and environmental changes during the perinatal period have been identified as potentially crucial factors. We have studied in a preclinical model early-onset molecular alter...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877820301575 |
id |
doaj-9a97067367eb42078f79e261e8535af8 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sarah Saget Rong Cong Lyvianne Decourtye Marie-Laure Endale Laetitia Martinerie Clémence Girardet Claire Perret Maud Clemessy Patricia Leneuve Laetitia Dinard Badreddine Mohand Oumoussa Dominique Farabos Antonin Lamazière Marc Lombès Marthe Moldes Bruno Fève David Tregouet Yves Le Bouc Laurent Kappeler |
spellingShingle |
Sarah Saget Rong Cong Lyvianne Decourtye Marie-Laure Endale Laetitia Martinerie Clémence Girardet Claire Perret Maud Clemessy Patricia Leneuve Laetitia Dinard Badreddine Mohand Oumoussa Dominique Farabos Antonin Lamazière Marc Lombès Marthe Moldes Bruno Fève David Tregouet Yves Le Bouc Laurent Kappeler Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice Molecular Metabolism Nutrition microRNA19a Histone modifications Epigenetics Biomarker DOHaD |
author_facet |
Sarah Saget Rong Cong Lyvianne Decourtye Marie-Laure Endale Laetitia Martinerie Clémence Girardet Claire Perret Maud Clemessy Patricia Leneuve Laetitia Dinard Badreddine Mohand Oumoussa Dominique Farabos Antonin Lamazière Marc Lombès Marthe Moldes Bruno Fève David Tregouet Yves Le Bouc Laurent Kappeler |
author_sort |
Sarah Saget |
title |
Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice |
title_short |
Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice |
title_full |
Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice |
title_fullStr |
Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice |
title_full_unstemmed |
Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice |
title_sort |
changes in circulating mirna19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice |
publisher |
Elsevier |
series |
Molecular Metabolism |
issn |
2212-8778 |
publishDate |
2020-12-01 |
description |
Objective: Individuals born with intrauterine growth retardation (IUGR) are more prone to cardio-metabolic diseases as adults, and environmental changes during the perinatal period have been identified as potentially crucial factors. We have studied in a preclinical model early-onset molecular alterations present before the development of a clinical phenotype. Methods: We used a preclinical mouse model of induced IUGR, in which we modulated the nutrition of the pups during the suckling period, to modify their susceptibility to cardio-metabolic diseases in adulthood. Results: Mice born with IUGR that were overfed (IUGR-O) during lactation rapidly developed obesity, hepatic steatosis and insulin resistance, by three months of age, whereas those subjected to nutrition restriction during lactation (IUGR-R) remained permanently thin and highly sensitive to insulin. Mice born with IUGR and fed normally during lactation (IUGR-N) presented an intermediate phenotype and developed insulin resistance by 12 months of age. Molecular alterations to the insulin signaling pathway with an early onset were observed in the livers of adult IUGR-N mice, nine months before the appearance of insulin resistance. The implication of epigenetic changes was revealed by ChIP sequencing, with both posttranslational H3K4me3 histone modifications and microRNAs involved. Conclusions: These two changes lead to the coherent regulation of insulin signaling, with a decrease in Akt gene transcription associated with an increase in the translation of its inhibitor, Pten. Moreover, we found that the levels of the implicated miRNA19a-3p also decreased in the blood of young adult IUGR mice nine months before the appearance of insulin resistance, suggesting a possible role for this miRNA as an early circulating biomarker of metabolic fate of potential use for precision medicine. |
topic |
Nutrition microRNA19a Histone modifications Epigenetics Biomarker DOHaD |
url |
http://www.sciencedirect.com/science/article/pii/S2212877820301575 |
work_keys_str_mv |
AT sarahsaget changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT rongcong changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT lyviannedecourtye changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT marielaureendale changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT laetitiamartinerie changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT clemencegirardet changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT claireperret changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT maudclemessy changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT patricialeneuve changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT laetitiadinard changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT badreddinemohandoumoussa changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT dominiquefarabos changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT antoninlamaziere changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT marclombes changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT marthemoldes changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT brunofeve changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT davidtregouet changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT yveslebouc changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice AT laurentkappeler changesincirculatingmirna19a3pprecedeinsulinresistanceprogrammedbyintrauterinegrowthretardationinmice |
_version_ |
1724401406450860032 |
spelling |
doaj-9a97067367eb42078f79e261e8535af82020-12-03T04:31:23ZengElsevierMolecular Metabolism2212-87782020-12-0142101083Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in miceSarah Saget0Rong Cong1Lyvianne Decourtye2Marie-Laure Endale3Laetitia Martinerie4Clémence Girardet5Claire Perret6Maud Clemessy7Patricia Leneuve8Laetitia Dinard9Badreddine Mohand Oumoussa10Dominique Farabos11Antonin Lamazière12Marc Lombès13Marthe Moldes14Bruno Fève15David Tregouet16Yves Le Bouc17Laurent Kappeler18Sorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceIHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceUniversité Paris Saclay, INSERM, UMR_S1185, Faculté de Médecine Paris Sud, F-94270, Le Kremlin-Bicêtre, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceIHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Sorbonne Université, INSERM, UMR_S1166, F-75013, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, FranceSorbonne Université, Inserm, UMS 29 Omique, Plateforme Post-Génomique de la Pitié-Salpêtrière, F-75013, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; Département de Métabolomique Clinique, Hôpital Saint Antoine, AP-HP, F-75012, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; Département de Métabolomique Clinique, Hôpital Saint Antoine, AP-HP, F-75012, Paris, FranceUniversité Paris Saclay, INSERM, UMR_S1185, Faculté de Médecine Paris Sud, F-94270, Le Kremlin-Bicêtre, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Department of Endocrinology, Saint Antoine Hospital, AP-HP, F-75012, Paris, FranceIHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Sorbonne Université, INSERM, UMR_S1166, F-75013, Paris, France; INSERM, UMR_S 1219, Bordeaux Population Health Research Center, F-33076, Bordeaux, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, FranceSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Corresponding author. Centre de Recherche St Antoine, CRSA, 34 Rue Crozatier, F-75012, Paris, France. Tel.: +33 149 284 664.Objective: Individuals born with intrauterine growth retardation (IUGR) are more prone to cardio-metabolic diseases as adults, and environmental changes during the perinatal period have been identified as potentially crucial factors. We have studied in a preclinical model early-onset molecular alterations present before the development of a clinical phenotype. Methods: We used a preclinical mouse model of induced IUGR, in which we modulated the nutrition of the pups during the suckling period, to modify their susceptibility to cardio-metabolic diseases in adulthood. Results: Mice born with IUGR that were overfed (IUGR-O) during lactation rapidly developed obesity, hepatic steatosis and insulin resistance, by three months of age, whereas those subjected to nutrition restriction during lactation (IUGR-R) remained permanently thin and highly sensitive to insulin. Mice born with IUGR and fed normally during lactation (IUGR-N) presented an intermediate phenotype and developed insulin resistance by 12 months of age. Molecular alterations to the insulin signaling pathway with an early onset were observed in the livers of adult IUGR-N mice, nine months before the appearance of insulin resistance. The implication of epigenetic changes was revealed by ChIP sequencing, with both posttranslational H3K4me3 histone modifications and microRNAs involved. Conclusions: These two changes lead to the coherent regulation of insulin signaling, with a decrease in Akt gene transcription associated with an increase in the translation of its inhibitor, Pten. Moreover, we found that the levels of the implicated miRNA19a-3p also decreased in the blood of young adult IUGR mice nine months before the appearance of insulin resistance, suggesting a possible role for this miRNA as an early circulating biomarker of metabolic fate of potential use for precision medicine.http://www.sciencedirect.com/science/article/pii/S2212877820301575NutritionmicroRNA19aHistone modificationsEpigeneticsBiomarkerDOHaD |